Protagonist Therapeutics
PTGX
PTGX
156 hedge funds and large institutions have $1.34B invested in Protagonist Therapeutics in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 40 increasing their positions, 60 reducing their positions, and 19 closing their positions.
Holders
156
Holders Change
+12
Holders Change %
+8.33%
% of All Funds
2.29%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.1%
New
32
Increased
40
Reduced
60
Closed
19
Calls
$14.5M
Puts
$2.47M
Net Calls
+$12.1M
Net Calls Change
+$977K
Top Buyers
1 |
1
Morgan Stanley
New York
|
$54.7M |
2 |
2
Point72 Asset Management
Stamford,
Connecticut
|
$59.9M |
3 |
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$20.9M |
4 |
![]()
4
Adage Capital Partners
Boston,
Massachusetts
|
$29.6M |
5 |
SC
5
Stempoint Capital
New York
|
$11.8M |